{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T12:55:44Z","timestamp":1780491344946,"version":"3.54.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2016,4,27]],"date-time":"2016-04-27T00:00:00Z","timestamp":1461715200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Z Rheumatol"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1007\/s00393-016-0078-2","type":"journal-article","created":{"date-parts":[[2016,4,27]],"date-time":"2016-04-27T08:37:53Z","timestamp":1461746273000},"page":"459-465","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["M\u00e4nnliche Osteoporose","Male osteoporosis"],"prefix":"10.1007","volume":"75","author":[{"given":"P.","family":"Farahmand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Spiegel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. D.","family":"Ringe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,4,27]]},"reference":[{"issue":"13","key":"78_CR1","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1503\/cmaj.071416","volume":"178","author":"C Berger","year":"2008","unstructured":"Berger C, Langsetmo L, Joseph L et\u00a0al (2008) Change in bone mineral density as a function of age in women and men and association with the use of antiresorptive agents. CMAJ 178(13):1660\u20131668","journal-title":"CMAJ"},{"key":"78_CR2","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1359\/jbmr.081214","volume":"24","author":"S Boonen","year":"2009","unstructured":"Boonen S, Orwoll ES, Wenderoth D et al (2009) Onceweekly risedronate in men with osteoporosis: results of a 2\u2011year, placebo-controlled, double-blind, multicenter study. J Bone Miner Res 24:719\u2013725","journal-title":"J Bone Miner Res"},{"key":"78_CR3","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1056\/NEJMoa1204061","volume":"367","author":"S Boonen","year":"2012","unstructured":"Boonen S, Reginster JY, Kaufman JM et\u00a0al (2012) Fracture risk reduction and zoledronic acid therapy in men with osteoporosis. N Engl J Med 367:1714\u20131723","journal-title":"N Engl J Med"},{"key":"78_CR4","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/S0140-6736(98)09075-8","volume":"353","author":"JR Center","year":"1999","unstructured":"Center JR, Nguyen TV, Schneider D et\u00a0al (1999) Mortality after all major types of osteoporotic fracture in men and women: an observational study. Lancet 353:878\u2013882","journal-title":"Lancet"},{"issue":"4","key":"78_CR5","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1359\/JBMR.040109","volume":"19","author":"KP Chang","year":"2004","unstructured":"Chang KP, Center JR, Nguyen TV et\u00a0al (2004) Incidence of hip and other osteoporotic fractures in elderly men and women: Dubbo Osteoporosis Epidemiology Study. J\u00a0Bone Miner Res 19(4):532\u2013536","journal-title":"J Bone Miner Res"},{"key":"78_CR6","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1056\/NEJMoa0809493","volume":"361","author":"SR Cummings","year":"2009","unstructured":"Cummings SR, San Martin J, McClung MR et\u00a0al (2009) Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med 361:756\u2013765","journal-title":"N Engl J Med"},{"key":"78_CR7","doi-asserted-by":"publisher","first-page":"907689","DOI":"10.1155\/2015\/907689","volume":"2015","author":"P D\u2019Amelio","year":"2015","unstructured":"D\u2019Amelio P, Isaia GC (2015) Male Osteoporosis in the Elderly. Int J Endocrinol 2015:907689 doi:10.1155\/2015\/907689","journal-title":"Int J Endocrinol"},{"key":"78_CR8","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1210\/jc.2011-3058","volume":"97","author":"MT Drake","year":"2012","unstructured":"Drake MT, Murad MH, Mauck KF et al (2012) Clinical review. Risk factors for low bone mass-related fractures in men: a systematic review and meta-analysis. J Clin Endocrinol Metab 97:1861\u20131870","journal-title":"J Clin Endocrinol Metab"},{"issue":"S1","key":"78_CR9","first-page":"S167","volume":"19","author":"P Farahmand","year":"2008","unstructured":"Farahmand P, Hermes S, Ringe JD (2008) Fracture status and risk factor constellation in 1056 male osteoporotic patients. Osteoporos Int 19(S1):S167","journal-title":"Osteoporos Int"},{"issue":"12","key":"78_CR10","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1007\/s00198-013-2379-5","volume":"24","author":"P Farahmand","year":"2013","unstructured":"Farahmand P, Marin F, Hawkins F et al (2013) Early changes in biochemical markers of bone formation during teriparatide therapy correlate with improvements in vertebral strength in men with glucocorticoid-induced osteoporosis. Osteoporos Int 24(12):2971\u20132981","journal-title":"Osteoporos Int"},{"issue":"4","key":"78_CR11","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1055\/s-0038-1630134","volume":"22","author":"P Farahmand","year":"2013","unstructured":"Farahmand P, Ringe JD, Feustel A et\u00a0al (2013) Fr\u00fcherkennung und Pr\u00e4vention der Osteoporose bei M\u00e4nnern. Osteologie 22(4):267\u2013270","journal-title":"Osteologie"},{"key":"78_CR12","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1001\/archinte.163.18.2165","volume":"163","author":"A Feldstein","year":"2003","unstructured":"Feldstein A, Elmer PJ, Orwoll E et al (2003) Bone mineral density measurement and treatment for osteoporosis in older individuals with fractures: a gap in evidence-based practice guideline implementation. Arch Intern Med 163:2165\u20132172","journal-title":"Arch Intern Med"},{"key":"78_CR13","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1007\/s00198-005-1950-0","volume":"16","author":"AC Feldstein","year":"2005","unstructured":"Feldstein AC, Nichols G, Orwoll E et\u00a0al (2005) The near absence of osteoporosis treatment in older men with fractures. Osteoporos Int 16:953\u2013962","journal-title":"Osteoporos Int"},{"issue":"6","key":"78_CR14","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1002\/jbmr.1870","volume":"28","author":"CC Gl\u00fcer","year":"2013","unstructured":"Gl\u00fcer CC, Marin F, Ringe JD et al (2013) Comparative effects of teriparatide and risedronate in glucocorticoid-induced osteoporosis in men: 18-month results of the EuroGIOPs trial. J Bone Miner Res 28(6):1355\u20131368","journal-title":"J Bone Miner Res"},{"issue":"4","key":"78_CR15","first-page":"52","volume":"110","author":"P Hadji","year":"2013","unstructured":"Hadji P, Klein S, Gothe H et\u00a0al (2013) The epidemiology of osteoporosis \u2013 Bone Evaluation Study (BEST): an analysis of routine health insurance data. Dtsch Arztebl Int 110(4):52\u201357","journal-title":"Dtsch Arztebl Int"},{"issue":"4","key":"78_CR16","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1055\/s-0038-1630136","volume":"22","author":"BC Hanusch","year":"2013","unstructured":"Hanusch BC, Tuck SP, Francis RM (2013) Male Osteoporosis Secondary causes. Osteologie 22(4):260\u2013266","journal-title":"Osteologie"},{"key":"78_CR17","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S8756-3282(03)00061-9","volume":"32","author":"JA Kanis","year":"2003","unstructured":"Kanis JA, Oden A, Johnell O et\u00a0al (2003) The components of excess mortality after hip fracture. Bone 32:468\u2013473","journal-title":"Bone"},{"key":"78_CR18","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1210\/jc.2012-3048","volume":"98","author":"JM Kaufman","year":"2013","unstructured":"Kaufman JM, Audran M, Bianchi G et\u00a0al (2013) Efficacy and safety of strontium ranelate in the treatment of osteoporosis in men. J\u00a0Clin Endocrinol Metab 98:592\u2013601","journal-title":"J Clin Endocrinol Metab"},{"issue":"19","key":"78_CR19","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1001\/archinte.162.19.2217","volume":"162","author":"GM Kiebzak","year":"2002","unstructured":"Kiebzak GM, Beinart GA, Perser K et\u00a0al (2002) Undertreatment of osteoporosis in men with hip fracture. Arch Intern Med 162(19):2217\u20132222","journal-title":"Arch Intern Med"},{"issue":"5","key":"78_CR20","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/j.1365-2265.1992.tb02355.x","volume":"37","author":"H Matzkin","year":"1992","unstructured":"Matzkin H, Chen J, Weisman Y et al (1992) Prolonged treatment with finasteride (a 5 alpha-reductase inhibitor) does not affect bone density and metabolism. Clin Endocrinol (Oxf) 37(5):432\u2013436","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"78_CR21","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1055\/s-0038-1630135","volume":"22","author":"C Meier","year":"2013","unstructured":"Meier C, Kraenzlin ME (2013) The influence of gonadal hormones on skeletal health in men. Osteologie 22(4):253\u2013259","journal-title":"Osteologie"},{"issue":"5","key":"78_CR22","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1210\/jc.2006-2613","volume":"92","author":"P Nordstr\u00f6m","year":"2007","unstructured":"Nordstr\u00f6m P, Neovius M, Nordstr\u00f6m A (2007) Early and rapid bone mineral density loss of the proximal femur in men. J\u00a0Clin Endocrinol Metab 92(5):1902\u20131908","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"78_CR23","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1002\/jbmr.5650110719","volume":"11","author":"TW O\u2019Neill","year":"1996","unstructured":"O\u2019Neill TW, Felsenberg D, Varlow J et\u00a0al (1996) The prevalence of vertebral deformity in european men and women: the European Vertebral Osteoporosis Study. J\u00a0Bone Miner Res 11(7):1010\u20131018","journal-title":"J Bone Miner Res"},{"key":"78_CR24","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1056\/NEJM200008313430902","volume":"343","author":"E Orwoll","year":"2000","unstructured":"Orwoll E, Ettinger M, Weiss S et\u00a0al (2000) Alendronate for the treatment of osteoporosis in men. N Engl J Med 343:604\u2013610","journal-title":"N Engl J Med"},{"key":"78_CR25","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1210\/jc.2012-1569","volume":"97","author":"E Orwoll","year":"2012","unstructured":"Orwoll E, Teglbjaerg CS, Langdahl BL et al (2012) A randomized, placebo-controlled study of the effects of denosumab for the treatment of men with low bone mineral density. J Clin Endocrinol Metab 97:3161\u20133169","journal-title":"J Clin Endocrinol Metab"},{"key":"78_CR26","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1359\/jbmr.2003.18.1.9","volume":"18","author":"ES Orwoll","year":"2003","unstructured":"Orwoll ES, Scheele WH, Paul S et\u00a0al (2003) The effect of teriparatide [human parathyroid hormone (1\u201334)] therapy on bone density in men with osteoporosis. J\u00a0Bone Miner Res 18:9\u201317","journal-title":"J Bone Miner Res"},{"issue":"1","key":"78_CR27","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1136\/ard.2004.034611","volume":"65","author":"I Pande","year":"2006","unstructured":"Pande I, Scott DL, O\u2019Neill TW et\u00a0al (2006) Quality of life, morbidity, and mortality after low trauma hip fracture in men. Ann Rheum Dis 65(1):87\u201392","journal-title":"Ann Rheum Dis"},{"key":"78_CR28","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/s00223-001-1060-8","volume":"69","author":"DM Reid","year":"2001","unstructured":"Reid DM, Adami S, Devogelaer JP et\u00a0al (2001) Risedronate increases bone density and reduces vertebral fracture risk within one year in men on corticosteroid therapy. Calcif Tissue Int 69:242\u2013247","journal-title":"Calcif Tissue Int"},{"key":"78_CR29","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s00296-003-0388-y","volume":"24","author":"JD Ringe","year":"2004","unstructured":"Ringe JD, Dorst A, Faber H et al (2004) Alendonate treatment of established primary osteoporosis in men: 3\u2011year results of a prospective, comparative, two-arm study. Rheumatol Int 24:110\u2013113","journal-title":"Rheumatol Int"},{"key":"78_CR30","first-page":"267","volume":"60","author":"JD Ringe","year":"2010","unstructured":"Ringe JD, Dorst A, Farahmand P (2010) Efficacy of strontium ranelate on bone mineral density in men with osteoporosis. Drug Res 60:267\u2013272","journal-title":"Drug Res"},{"key":"78_CR31","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00296-005-0004-4","volume":"26","author":"JD Ringe","year":"2006","unstructured":"Ringe JD, Faber H, Farahmand P et al (2006) Efficacy of risedronate in men with primary and secondary osteoporosis. Results of a 1\u2011year study. Rheumatol Int 26:427\u2013431","journal-title":"Rheumatol Int"},{"issue":"5","key":"78_CR32","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s00296-012-2663-2","volume":"34","author":"JD Ringe","year":"2014","unstructured":"Ringe JD, Farahmand P (2014) Improved real-life adherence of 6\u2011monthly Denosumab injections due to positive feedback based on rapid 6\u2011months BMD increase and good safety profile. Rheumatol Int 34(5):727\u2013732","journal-title":"Rheumatol Int"},{"key":"78_CR33","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s00296-008-0689-2","volume":"29","author":"JD Ringe","year":"2009","unstructured":"Ringe JD, Farahmand P, Faber H et al (2009) Sustained efficacy of risedronate in men with primary and secondary osteoporosis: results of a 2\u2011year study. Rheumatol Int 29:311\u2013315","journal-title":"Rheumatol Int"},{"issue":"3","key":"78_CR34","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s00296-012-2429-x","volume":"33","author":"JD Ringe","year":"2013","unstructured":"Ringe JD, Farahmand P, Schacht E (2013) Alfacalcidol in men with osteoporosis: a prospective, observational, 2\u2011year trial on 214 patients. Rheumatol Int 33(3):637\u2013643","journal-title":"Rheumatol Int"},{"issue":"7529","key":"78_CR35","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1136\/bmj.38643.663843.55","volume":"331","author":"JJ Roche","year":"2005","unstructured":"Roche JJ, Wenn RT, Sahota O et\u00a0al (2005) Effect of comorbidities and postoperative complications on mortality after hip fracture in elderly people: prospective observational cohort study. BMJ 331(7529):1374","journal-title":"BMJ"},{"issue":"1","key":"78_CR36","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.bone.2003.10.001","volume":"34","author":"SC Schuit","year":"2004","unstructured":"Schuit SC, van der Klift M, Weel AE et\u00a0al (2004) Fracture incidence and association with bone mineral density in elderly men and women: the Rotterdam Study. Bone 34(1):195\u2013202","journal-title":"Bone"},{"key":"78_CR37","volume-title":"Falling standards, broken promises. Report of the national audit of falls and bone health in older people 2010","author":"J Treml","year":"2011","unstructured":"Treml J, Husk J, Lowe D et\u00a0al (2011) Falling standards, broken promises. Report of the national audit of falls and bone health in older people 2010. Royal College of Physicians, London"},{"issue":"6","key":"78_CR38","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S8756-3282(01)00614-7","volume":"29","author":"TP Staa van","year":"2001","unstructured":"van Staa TP, Dennison EM, Leufkens HG et\u00a0al (2001) Epidemiology of fractures in England and Wales. Bone 29(6):517\u2013522","journal-title":"Bone"}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-016-0078-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00393-016-0078-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-016-0078-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-016-0078-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,7]],"date-time":"2019-09-07T02:09:50Z","timestamp":1567822190000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00393-016-0078-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,27]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["78"],"URL":"https:\/\/doi.org\/10.1007\/s00393-016-0078-2","relation":{},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"value":"0340-1855","type":"print"},{"value":"1435-1250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,27]]}}}